A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitus

According to our preliminary findings, genetic variation in the INSR and HNF1A genes may differentially affect weight loss in obese individuals treated with topiramate and genes related to insulin action are implicated in modulating topiramate response. However, these findings need to be further replicated in additional larger samples.